Intimal sarcoma of the left ventricle: the contribution of multimodal imaging Primary cardiac intimal sarcoma is a rare malignant mesenchymal neoplasm whose complex intracavitary appearance frequently mimics more common pathologies such as... Oct 3, 2026
Cardiac robotics: repairing mitral and tricuspid valves after sternotomy Mitral reoperation following median sternotomy presents a major technical challenge due to dense retrosternal adhesions, which expose the patient to a... Oct 2, 2026
Mitral repair or replacement: what is the survival rate in severely dilated ventricles? Managing complex degenerative mitral regurgitation (DMR) is particularly challenging due to associated left ventricular dilatation (LVD), defined by... Oct 1, 2026
3D endoscopic mitral valve repair and dextrocardia: the left atrial appendage landmark Situs inversus totalis with mirror-image dextrocardia dictates a complete anatomical shift. For the cardiac surgeon, this atypical configuration presents unique complexities. Oct 1, 2026
Post-CABG tricuspid regurgitation: TEE to detect a structural cause The onset of severe tricuspid regurgitation (TR) during weaning from cardiopulmonary bypass (CPB) presents a major diagnostic challenge for the surgical team. Bi... Sep 30, 2026
Pulmonary artery rupture via Swan-Ganz: the role of intraoperative embolization While standard for hemodynamic monitoring in cardiac surgery, the use of the Swan-Ganz catheter (PAC) carries a rare but potentially fatal risk of... Sep 28, 2026
M-TEER and cancer: a technical success but increased long-term mortality The prevalence of valvular pathologies in patients with a history of or active cancer raises increasing questions in clinical practice. Sep 26, 2026
Severe MR: Should mitral valve replacement be preferred over repair? Severe ischemic mitral regurgitation (IM), a common post-myocardial infarction complication, is associated with high mortality and often necessitates surgical intervention. Sep 25, 2026
Mitral valve-in-valve: crossing a calcified interatrial septum Transcatheter mitral valve-in-valve replacement (TMVR) in patients with a history of complex cardiac surgery represents a significant technical challenge. Sep 24, 2026
M-TEER: estimated plasma volume predicts 5-year mortality Volume overload and systemic congestion are major determinants of morbidity and mortality in patients with severe mitral regurgitation. Sep 23, 2026
M-TEER: AI and ultrasound combined to predict mortality risk Percutaneous edge-to-edge mitral valve repair (M-TEER) has established itself as an essential therapeutic option for patients with mitral regurgitation. Sep 22, 2026
Rheumatic heart disease: mitral valve repair outperforms replacement Rheumatic mitral valve disease remains a major global public health issue, causing nearly 320,000 deaths annually. While mitral valve replacement (MVR)... Sep 19, 2026